FDA Inspection
Baptist Health IRB #1Baptist Health IRB #1 – FDA Inspection, Feb 22, 2018
Record Details
This FDA Inspection record concerns Baptist Health IRB #1, with an inspection on February 22, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 4ac90b6f-fd55-45da-abfe-25672c25cb36
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1041815
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 56.115(a)(2)Minutes of IRB meetings
- 21 CFR 56.110(c)Method to keep members advised
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Baptist Health IRB #1
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 28, 2023 | VAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| February 8, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Baptist Health IRB #1
- FDA Inspection 1219429 - 2023-09-28
- FDA Inspection 768288 - 2012-02-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.